Inclusion of Under-represented Racial and Ethnic Minorities in Randomized Clinical Trials for Inflammatory Bowel Disease.
作者信息
Cohen Nathaniel A, Silfen Alexa, Rubin David T
机构信息
Medicine Inflammatory Bowel Disease Center, University of Chicago, Chicago, Illinois.
Medicine Inflammatory Bowel Disease Center, MacLean Center for Clinical Medical Ethics, University of Chicago, Chicago, Illinois.
出版信息
Gastroenterology. 2022 Jan;162(1):17-21. doi: 10.1053/j.gastro.2021.09.035. Epub 2021 Sep 22.
Abstract
摘要
相似文献
1
Inclusion of Under-represented Racial and Ethnic Minorities in Randomized Clinical Trials for Inflammatory Bowel Disease.
Gastroenterology. 2022 Jan;162(1):17-21. doi: 10.1053/j.gastro.2021.09.035. Epub 2021 Sep 22.
2
Underrepresentation of Minorities and Underreporting of Race and Ethnicity in Crohn's Disease Clinical Trials.
Gastroenterology. 2022 Jan;162(1):338-340.e2. doi: 10.1053/j.gastro.2021.09.054. Epub 2021 Sep 27.
3
Underrepresentation of Ethnic and Racial Minorities in Atrial Fibrillation Clinical Trials.
Circ Arrhythm Electrophysiol. 2021 Dec;14(12):e010452. doi: 10.1161/CIRCEP.121.010452. Epub 2021 Nov 18.
4
Diversity and Inclusion in Pancreatic Cancer Clinical Trials.
Gastroenterology. 2021 Dec;161(6):1741-1746.e3. doi: 10.1053/j.gastro.2021.06.079. Epub 2021 Aug 17.
5
Biologics for inflammatory bowel diseases in the Asia-Pacific: can we afford to use them, can we afford not to?
J Gastroenterol Hepatol. 2009 Jul;24(7):1160-2. doi: 10.1111/j.1440-1746.2009.05896.x.
6
Tofacitinib, two-faced Janus in ulcerative colitis and Crohn's disease?
United European Gastroenterol J. 2020 Aug;8(7):753-754. doi: 10.1177/2050640620942641. Epub 2020 Jul 8.
7
Racial and ethnic representation in peripheral artery disease randomized clinical trials.
Ann Vasc Surg. 2024 Nov;108:355-364. doi: 10.1016/j.avsg.2024.05.034. Epub 2024 Jul 14.
8
Vedolizumab for the treatment of ulcerative colitis.
Expert Opin Biol Ther. 2016;16(1):129-35. doi: 10.1517/14712598.2016.1121231. Epub 2015 Dec 9.
9
Assessing disease activity and disease activity indices for inflammatory bowel disease.
Curr Gastroenterol Rep. 2002 Dec;4(6):490-6. doi: 10.1007/s11894-002-0025-z.
10
How Failure Can Fuel Improvements in Early Drug Development for Inflammatory Bowel Diseases.
Gastroenterology. 2016 May;150(5):1061-1066. doi: 10.1053/j.gastro.2016.03.011. Epub 2016 Mar 24.
引用本文的文献
1
Leveraging In Silico and Artificial Intelligence Models to Advance Drug Disposition and Response Predictions Across the Lifespan.
Clin Transl Sci. 2025 Jun;18(6):e70272. doi: 10.1111/cts.70272.
2
Advancing therapeutic frontiers: a pipeline of novel drugs for luminal and perianal Crohn's disease management.
Therap Adv Gastroenterol. 2024 Dec 19;17:17562848241303651. doi: 10.1177/17562848241303651. eCollection 2024.
3
Interpreting modern randomized controlled trials of medical therapy in inflammatory bowel disease.
Nat Rev Gastroenterol Hepatol. 2024 Nov;21(11):792-808. doi: 10.1038/s41575-024-00989-y. Epub 2024 Oct 8.
4
Navigating the complexities of drug development for inflammatory bowel disease.
Nat Rev Drug Discov. 2024 Jul;23(7):546-562. doi: 10.1038/s41573-024-00953-0. Epub 2024 May 22.
5
Assessing ascertainment bias in atrial fibrillation across US minority groups.
PLoS One. 2024 Apr 16;19(4):e0301991. doi: 10.1371/journal.pone.0301991. eCollection 2024.
6
Improved clinical trial race/ethnicity reporting and updated inclusion profile, 2017-2022: A New Jersey snapshot.
Glob Epidemiol. 2023 Dec 23;7:100134. doi: 10.1016/j.gloepi.2023.100134. eCollection 2024 Jun.
7
Trends in Patient Representation in Low Back Pain Pharmacological Randomized Clinical Trials, 2011 to 2020: A Systematic Review.
J Pain. 2024 Jun;25(6):104456. doi: 10.1016/j.jpain.2023.12.013. Epub 2024 Jan 6.
8
Racial and Ethnic Disparities in Inflammatory Bowel Disease.
Gastroenterol Hepatol (N Y). 2023 May;19(5):281-283.
9
Leveraging Virtual Technology to Conduct Clinical Trials in Inflammatory Bowel Disease.
Gastroenterol Hepatol (N Y). 2023 Aug;19(8):468-474.
10
Geographic Inequities in Access to Phase 3 Clinical Trials for Inflammatory Bowel Disease in the United States.
Clin Gastroenterol Hepatol. 2024 Mar;22(3):659-661.e3. doi: 10.1016/j.cgh.2023.07.026. Epub 2023 Aug 11.
本文引用的文献
1
Minority Representation in Clinical Trials in the United States: Trends Over the Past 25 Years.
Mayo Clin Proc. 2021 Jan;96(1):264-266. doi: 10.1016/j.mayocp.2020.10.027.
2
The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
Lancet Gastroenterol Hepatol. 2020 Jan;5(1):17-30. doi: 10.1016/S2468-1253(19)30333-4. Epub 2019 Oct 21.
3
Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018.
JAMA Oncol. 2019 Oct 1;5(10):e191870. doi: 10.1001/jamaoncol.2019.1870. Epub 2019 Oct 10.
4
Incidence of inflammatory bowel disease by race and ethnicity in a population-based inception cohort from 1970 through 2010.
Therap Adv Gastroenterol. 2019 Feb 6;12:1756284819827692. doi: 10.1177/1756284819827692. eCollection 2019.
5
Racial and Ethnic Disparities in Health Insurance Coverage: Dynamics of Gaining and Losing Coverage over the Life-Course.
Popul Res Policy Rev. 2017 Apr;36(2):181-201. doi: 10.1007/s11113-016-9416-y. Epub 2016 Oct 15.
6
Racial and Ethnic Health Disparities and the Affordable Care Act: a Status Update.
J Racial Ethn Health Disparities. 2015 Dec;2(4):583-8. doi: 10.1007/s40615-015-0113-z. Epub 2015 Jul 3.
7
A new initiative on precision medicine.
N Engl J Med. 2015 Feb 26;372(9):793-5. doi: 10.1056/NEJMp1500523. Epub 2015 Jan 30.
8
Racial/ethnic disparities in chronic diseases of youths and access to health care in the United States.
Biomed Res Int. 2013;2013:787616. doi: 10.1155/2013/787616. Epub 2013 Sep 23.
9
Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study.
Gastroenterology. 2013 Jul;145(1):158-165.e2. doi: 10.1053/j.gastro.2013.04.007. Epub 2013 Apr 9.
10
Reporting and representation of race/ethnicity in published randomized trials.
Am Heart J. 2009 Nov;158(5):742-7. doi: 10.1016/j.ahj.2009.08.018. Epub 2009 Sep 29.
Zotero 插件